Knee osteoarthritis can make ordinary life feel smaller. Stairs become a calculation, a walk around the block takes planning, and even standing in a grocery line can turn into a test of patience.
A new study from Berlin suggests that a minimally invasive procedure may help some patients stuck in the painful middle ground.
The treatment, called genicular artery embolization, reduced pain and improved function for at least one year in people whose knee arthritis had not responded well to standard care.
A major cause of pain
Osteoarthritis is a joint disease that causes pain, swelling, stiffness, and trouble moving. The World Health Organization says about 528 million people worldwide were living with osteoarthritis in 2019, and the knee was the most commonly affected joint, with a prevalence of 365 million.
That matters because knee pain is not just a medical chart problem. It can limit work, exercise, sleep, errands, and the small daily movements most people barely notice until they hurt.
The treatment gap
Doctors usually start with physical therapy, anti-inflammatory drugs, and injections into the joint. But what happens when those steps no longer work, and a knee replacement is not the right choice?
Florian Nima Fleckenstein of Charité – Universitätsmedizin Berlin described that problem as a real “treatment gap.” He said some patients no longer get enough relief from conservative care, while surgery may be off the table for medical or personal reasons.
How the procedure works
Genicular artery embolization targets unusual blood vessels that form around the arthritic knee. These vessels are tied to long-lasting inflammation and nerve activity that can help keep pain signals switched on.
During the procedure, an interventional radiologist guides a thin catheter through the blood vessels to the painful area.
Tiny gelatin-based beads are then injected to block the abnormal flow, and those beads are designed to dissolve within hours. Think of it as closing a troublesome side road without shutting down the whole highway.
Who was studied
The Berlin study included 194 people with knee osteoarthritis pain that had resisted at least three months of conservative treatment. The group included 114 women and 80 men, with a median age of 69.
Some patients had pain in both knees. In total, the researchers performed 239 procedures, and 45 participants received treatment on both knees within four weeks.
Pain scores dropped
The most attention-grabbing result was pain relief. On a scale from zero to 10, the median pain score fell from 7 before treatment to 4 after six weeks, then to 3 at both six months and 12 months.
That is not a tiny shift on paper. For many patients, a change like that can mean standing up more easily, walking farther, or getting through the day with fewer reminders from a sore joint.
Daily function improved
Pain was not the only measure that changed. Scores for daily activities rose from 53 to 71.5 after one year, while sports and recreation scores rose from 15 to 36.
Quality-of-life scores also improved, rising from 19 to 40. At the 12-month mark, 80% of participants reached a level of pain improvement considered clinically meaningful, meaning the change was large enough to matter in real life.
Safety was closely watched
The procedure was done with fluoroscopic guidance, a type of live X-ray imaging that helps doctors see where the catheter is going. All procedures were technically successful, according to the study.
No moderate or severe adverse events were reported. Mild, self-limited reactions occurred in 6.7% of procedures, including temporary skin discoloration and one superficial groin bruise that resolved without lasting effects.
Why the beads matter
The gelatin microspheres are important because they are temporary. Older approaches can use permanent materials, while another method uses an antibiotic mixture that has its own limits.
The newer beads aim to combine precision with a shorter-lasting blockage. That could reduce concerns about long-term side effects, although researchers still need more data before anyone treats this as a finished story.
Part of a growing field
This study did not appear out of nowhere. A separate open-access study in CardioVascular and Interventional Radiology, published in November 2025, also reported short-term clinical improvement after genicular artery embolization using resorbable gelatin microspheres, with no major complications in its 45-patient group.
Still, the Berlin work stands out because it followed a larger real-world group for a full year. That gives doctors more practical information about what patients might expect beyond the first few weeks.
What patients should know
This is not being presented as a cure for knee osteoarthritis. It also does not replace exercise, weight management when needed, medication, injections, or surgery for patients who clearly need a new joint.
For carefully selected patients, though, it may become a useful option between injections and replacement surgery. The key question now is how well these results hold up in larger, multi-center trials with direct comparisons to other treatments.
The main study has been published in Radiology, a journal of the Radiological Society of North America.
